HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study.

AbstractOBJECTIVE:
To examine the association of vasodilator and antihypertensive medication use with the incidence of age-related macular degeneration (AMD).
DESIGN:
Longitudinal population-based study.
PARTICIPANTS:
Persons 43 to 86 years of age living in Beaver Dam, Wisconsin, from 1988 through 1990.
METHODS:
Examinations were performed every 5 years over a 20-year period. There were 9676 total person-visits over the course of the study. Status of AMD was determined from grading retinal photographs.
MAIN OUTCOME MEASURES:
Incidence of AMD.
RESULTS:
The 5-year incidence of early AMD over the 20-year period was 8.4%; for late AMD, it was 1.4%; for pure geographic atrophy (GA), it was 0.6%; for exudative AMD, it was 0.9%; and for progression of AMD, it was 24.9%. While adjusting for age, gender, and other factors, using a vasodilator (hazard ratio [HR], 1.72; 95% confidence interval [CI], 1.25-2.38), particularly oral nitroglycerin (HR, 1.81; 95% CI, 1.14-2.90), was associated with an increased risk of early AMD. Using an oral β-blocker was associated with an increased hazard of incident exudative AMD (HR, 1.71; 95% CI, 1.04-2.82), but not pure GA (HR, 0.51; 95% CI, 0.20-1.29) or progression of AMD (HR, 0.92; 95% CI, 0.67-1.28) over the 20-year period.
CONCLUSIONS:
Use of vasodilators is associated with a 72% increase in the hazard of incidence of early AMD, and use of oral β-blockers is associated with a 71% increase in the hazard of incident exudative AMD. If these findings are replicated, it may have implications for care of older adults because vasodilators and oral β-blockers are drugs that are used commonly by older persons.
AuthorsRonald Klein, Chelsea E Myers, Barbara E K Klein
JournalOphthalmology (Ophthalmology) Vol. 121 Issue 8 Pg. 1604-11 (Aug 2014) ISSN: 1549-4713 [Electronic] United States
PMID24793737 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Vasodilator Agents
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents (therapeutic use)
  • Blood Pressure (drug effects)
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension (drug therapy)
  • Incidence
  • Macular Degeneration (diagnosis, epidemiology)
  • Male
  • Middle Aged
  • Photography
  • Risk Factors
  • Sex Distribution
  • Vasodilator Agents (therapeutic use)
  • Wisconsin (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: